Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Overview
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 21-02-2025
NAV ₹35.1(R) -1.4% ₹37.69(D) -1.39%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 15.77% 22.66% 25.85% -% -%
Direct 16.76% 23.75% 27.02% -% -%
Nifty Pharma TRI 8.49% 16.98% 20.4% 13.51% 6.47%
SIP (XIRR) Regular 4.38% 27.21% 22.93% -% -%
Direct 5.34% 28.34% 24.02% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.98 0.53 1.13 6.98% 0.17
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.47% -18.14% -10.24% 0.9 10.66%
Top Pharma Fund
Fund Name Rank Rating
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -
Nippon India Pharma Fund -
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -

NAV Date: 21-02-2025

Scheme Name NAV Rupee Change Percent Change
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option 22.33
-0.3100
-1.3700%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option 24.6
-0.3500
-1.4000%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 35.1
-0.5000
-1.4000%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option 37.69
-0.5300
-1.3900%

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It captures the increment in the investment's value during the investment period, articulated as either a percentage or a monetary denomination. We carefully examined six return parameters of this fund to gauge its performance. The return parameters have been divided into three performance groups: the top 25%, parameters below the top 25% but exceeding the average, and parameters below the average mark. Please find the detailed analysis below.
    1. Top 25%: Four return parameters of the Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund are in the top 25% in the category, as shown below:
      • 3M Return %
      • 1Y Return %
      • 3Y Return %
      • 5Y Return %
    2. Above Average Below the Top 25%: The Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has one return parameter in the category, which is above average but below the top 25%, as listed below:
      • 6M Return %
    3. Below Average: One return parameter of the fund is below average in the category, which is listed below:
      • 1M Return %
  2. Risk: The threat of not realizing projected profits or even facing financial loss due to different issues is known as risk. For Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has one risk parameter that is below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.47 %.
    3. Above Average: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has one parameter that is above average which is listed below:
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.66 %.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund, we have evaluated four risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has four risk-adjusted performance parameters of the fund that are in the top 25% of the category.
      • Sharpe Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sharpe Ratio of 0.98 compared to the category average of 0.79.
      • Sterling Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sterling Ratio of 1.13 compared to the category average of 0.93.
      • Sortino Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sortino Ratio of 0.53 compared to the category average of 0.43.
      • Treynor Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Treynor Ratio of 0.17 compared to the category average of 0.14.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.49 -6.64
-6.97
-9.04 | -5.72 9 | 13 Average
3M Return % -5.95 -6.02
-6.79
-9.68 | -4.84 4 | 13 Very Good
6M Return % -5.62 -9.49
-6.24
-17.69 | -0.25 6 | 13 Good
1Y Return % 15.77 8.49
11.55
1.74 | 21.28 3 | 13 Very Good
3Y Return % 22.66 16.98
19.78
17.06 | 22.67 2 | 8 Very Good
5Y Return % 25.85 20.40
23.20
19.41 | 25.85 1 | 8 Very Good
1Y SIP Return % 4.38
1.08
-11.88 | 13.28 4 | 13 Very Good
3Y SIP Return % 27.21
23.30
20.70 | 27.21 1 | 8 Very Good
5Y SIP Return % 22.93
20.31
17.57 | 22.93 1 | 8 Very Good
Standard Deviation 15.47
15.52
14.01 | 16.25 4 | 8 Good
Semi Deviation 10.66
10.65
10.12 | 11.03 5 | 8 Average
Max Drawdown % -10.24
-11.33
-13.44 | -9.85 2 | 8 Very Good
VaR 1 Y % -18.14
-18.16
-22.20 | -15.67 5 | 8 Average
Average Drawdown % -4.56
-5.01
-6.33 | -4.14 3 | 8 Good
Sharpe Ratio 0.98
0.79
0.59 | 1.08 2 | 8 Very Good
Sterling Ratio 1.13
0.93
0.76 | 1.16 2 | 8 Very Good
Sortino Ratio 0.53
0.43
0.32 | 0.56 2 | 8 Very Good
Jensen Alpha % 6.98
3.87
0.23 | 8.88 2 | 8 Very Good
Treynor Ratio 0.17
0.14
0.10 | 0.19 2 | 8 Very Good
Modigliani Square Measure % 24.67
21.33
17.54 | 27.27 2 | 8 Very Good
Alpha % 5.23
2.09
-0.60 | 5.31 2 | 8 Very Good
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.42 -6.64 -6.87 -8.93 | -5.64 9 | 13
3M Return % -5.75 -6.02 -6.48 -9.30 | -4.55 4 | 13
6M Return % -5.21 -9.49 -5.62 -16.99 | 0.61 7 | 13
1Y Return % 16.76 8.49 13.01 3.43 | 22.79 3 | 13
3Y Return % 23.75 16.98 21.22 18.82 | 23.98 2 | 8
5Y Return % 27.02 20.40 24.74 21.24 | 27.02 1 | 8
1Y SIP Return % 5.34 2.46 -10.32 | 14.73 5 | 13
3Y SIP Return % 28.34 24.80 22.30 | 28.34 1 | 8
5Y SIP Return % 24.02 21.78 19.27 | 24.02 1 | 8
Standard Deviation 15.47 15.52 14.01 | 16.25 4 | 8
Semi Deviation 10.66 10.65 10.12 | 11.03 5 | 8
Max Drawdown % -10.24 -11.33 -13.44 | -9.85 2 | 8
VaR 1 Y % -18.14 -18.16 -22.20 | -15.67 5 | 8
Average Drawdown % -4.56 -5.01 -6.33 | -4.14 3 | 8
Sharpe Ratio 0.98 0.79 0.59 | 1.08 2 | 8
Sterling Ratio 1.13 0.93 0.76 | 1.16 2 | 8
Sortino Ratio 0.53 0.43 0.32 | 0.56 2 | 8
Jensen Alpha % 6.98 3.87 0.23 | 8.88 2 | 8
Treynor Ratio 0.17 0.14 0.10 | 0.19 2 | 8
Modigliani Square Measure % 24.67 21.33 17.54 | 27.27 2 | 8
Alpha % 5.23 2.09 -0.60 | 5.31 2 | 8
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -1.40 ₹ 9,860.00 -1.39 ₹ 9,861.00
1W -1.29 ₹ 9,871.00 -1.26 ₹ 9,874.00
1M -7.49 ₹ 9,251.00 -7.42 ₹ 9,258.00
3M -5.95 ₹ 9,405.00 -5.75 ₹ 9,425.00
6M -5.62 ₹ 9,438.00 -5.21 ₹ 9,479.00
1Y 15.77 ₹ 11,577.00 16.76 ₹ 11,676.00
3Y 22.66 ₹ 18,454.00 23.75 ₹ 18,949.00
5Y 25.85 ₹ 31,565.00 27.02 ₹ 33,061.00
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 4.38 ₹ 12,284.53 5.34 ₹ 12,345.82
3Y ₹ 36000 27.21 ₹ 53,376.48 28.34 ₹ 54,192.02
5Y ₹ 60000 22.93 ₹ 106,056.36 24.02 ₹ 108,889.20
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund NAV Regular Growth Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund NAV Direct Growth
21-02-2025 35.1 37.69
20-02-2025 35.6 38.22
19-02-2025 35.43 38.04
18-02-2025 35.57 38.19
17-02-2025 35.8 38.44
14-02-2025 35.56 38.17
13-02-2025 36.39 39.07
12-02-2025 36.11 38.76
11-02-2025 36.24 38.9
10-02-2025 37.09 39.82
07-02-2025 37.84 40.62
06-02-2025 38.01 40.8
05-02-2025 37.7 40.47
04-02-2025 37.45 40.2
03-02-2025 36.97 39.68
31-01-2025 37.13 39.85
30-01-2025 36.96 39.67
29-01-2025 36.57 39.24
28-01-2025 35.95 38.58
27-01-2025 36.55 39.23
24-01-2025 37.48 40.22
23-01-2025 38.39 41.19
22-01-2025 37.91 40.68
21-01-2025 37.94 40.71

Fund Launch Date: 25/Jun/2018
Fund Category: Pharma Fund
Investment Objective: To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Fund Description: An Open Ended Equity Scheme following Pharma, Healthcare, Diagnostic and allied Theme
Fund Benchmark: S&P BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.